Detalhe da pesquisa
1.
Adaptive Evolution of Pseudomonas aeruginosa in Human Airways Shows Phenotypic Convergence Despite Diverse Patterns of Genomic Changes.
Mol Biol Evol
; 41(2)2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38366124
2.
Structure of Pseudomonas aeruginosa ribosomes from an aminoglycoside-resistant clinical isolate.
Proc Natl Acad Sci U S A
; 116(44): 22275-22281, 2019 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31611393
3.
Influence of the Crc global regulator on substrate uptake rates and the distribution of metabolic fluxes in Pseudomonas putida KT2440 growing in a complete medium.
Environ Microbiol
; 21(11): 4446-4459, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31595602
4.
Influence of the Crc regulator on the hierarchical use of carbon sources from a complete medium in Pseudomonas.
Environ Microbiol
; 18(3): 807-18, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26568055
5.
The Crc/CrcZ-CrcY global regulatory system helps the integration of gluconeogenic and glycolytic metabolism in Pseudomonas putida.
Environ Microbiol
; 17(9): 3362-78, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25711694
6.
The Crc and Hfq proteins of Pseudomonas putida cooperate in catabolite repression and formation of ribonucleic acid complexes with specific target motifs.
Environ Microbiol
; 17(1): 105-18, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24803210
7.
The Crc protein inhibits the production of polyhydroxyalkanoates in Pseudomonas putida under balanced carbon/nitrogen growth conditions.
Environ Microbiol
; 16(1): 278-90, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24118893
8.
Differential proteomic analysis of an engineered Streptomyces coelicolor strain reveals metabolic pathways supporting growth on n-hexadecane.
Appl Microbiol Biotechnol
; 94(5): 1289-301, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22526801
9.
Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution.
Antibiotics (Basel)
; 11(3)2022 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35326882
10.
Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance.
Clin Microbiol Infect
; 28(12): 1594-1601, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35988850
11.
Compensatory evolution of Pseudomonas aeruginosa's slow growth phenotype suggests mechanisms of adaptation in cystic fibrosis.
Nat Commun
; 12(1): 3186, 2021 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34045458
12.
High-throughput dilution-based growth method enables time-resolved exo-metabolomics of Pseudomonas putida and Pseudomonas aeruginosa.
Microb Biotechnol
; 14(5): 2214-2226, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34327837
13.
Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis.
Nat Rev Microbiol
; 19(5): 331-342, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33214718
14.
Adapting to the Airways: Metabolic Requirements of Pseudomonas aeruginosa during the Infection of Cystic Fibrosis Patients.
Metabolites
; 9(10)2019 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31623245
15.
Convergent Metabolic Specialization through Distinct Evolutionary Paths in Pseudomonas aeruginosa.
mBio
; 9(2)2018 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29636437
16.
Editorial: Pseudomonas aeruginosa Pathogenesis: Virulence, Antibiotic Tolerance and Resistance, Stress Responses and Host-Pathogen Interactions.
Front Cell Infect Microbiol
; 12: 860314, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35242722
17.
Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance: author's response.
Clin Microbiol Infect
; 28(12): 1667-1668, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150672